The ND2 subunit is labeled by a photoaffinity analogue of asimicin, a potent complex I inhibitor
Abstract
NADH:ubiquinone oxidoreductase (complex I) is the entry enzyme of mitochondrial oxidative phosphorylation. To obtain the structural information on inhibitor/quinone binding sites, we synthesized [3H]benzophenone-asimicin ([3H]BPA), a photoaffinity analogue of asimicin, which belongs to the acetogenin family known as the most potent complex I inhibitor. We found that [3H]BPA was photo-crosslinked to ND2, ND1 and ND5 subunits, by the three dimensional separation (blue-native/doubled SDS–PAGE) of [3H]BPA-treated bovine heart submitochondrial particles. The cross-linking was blocked by rotenone. This is the first finding that ND2 was photo-crosslinked with a potent complex I inhibitor, suggesting its involvement in the inhibitor/quinone-binding.
Abbreviations: BN–PAGE, blue native-PAGE, BPA, benzophenone-asimicin, 1-D, one-dimensional, 2-D, two-dimensional, 3-D, three-dimensional, IC50, the molar concentration of substance that provides 50% inhibition of the control NADH oxidase activity, Q, quinone, SMP, submitochondrial particles, SQ, semiquinone, [125I]TDA, [125I](trifluoromethyl)phenyldiazirinylacetogenin
Keywords: Complex I, Bovine heart mitochondria, Asimicin, ND2, Photoaffinity labeling, Quinone binding
To access this article, please choose from the options below
PII: S0014-5793(10)00021-9
doi:10.1016/j.febslet.2010.01.004
© 2010 Federation of European Biochemical Societies
